Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

20.0%

2 terminated out of 10 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 4 (1)

Trial Status

Completed4
Terminated2
Recruiting2
Not Yet Recruiting1
Unknown1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (10)

Research Network

Activity Timeline